Role of Probiotics in Modulating Human Gut Microbiota Populations and Activities in Patients with Colorectal Cancer-A Systematic Review of Clinical Trials
- PMID: 33915854
- PMCID: PMC8066620
- DOI: 10.3390/nu13041160
Role of Probiotics in Modulating Human Gut Microbiota Populations and Activities in Patients with Colorectal Cancer-A Systematic Review of Clinical Trials
Abstract
Background: Growing attention has been given to the role of nutrition and alterations of microbial diversity of the gut microbiota in colorectal cancer (CRC) pathogenesis. It has been suggested that probiotics and synbiotics modulate enteric microbiota and therefore may be used as an intervention to reduce the risk of CRC. The aim of this study was to evaluate the influence of probiotics/synbiotics administration on gut microbiota in patients with CRC.
Methods: PubMed, Scopus, and Web of Science were searched between December 2020 and January 2021. Randomized controlled trials (RCTs) recruiting adults with CRC, who have taken probiotics/synbiotics for at least 6 days were included. Changes in gut microbiota and selected biochemical and inflammatory parameters (i.e., hsCRP, IL-2, hemoglobin) were retrieved.
Results: The search resulted in 198 original research articles and a final 6 were selected as being eligible, including 457 subjects. The median age of patients was 65.4 years old and they were characterized by the median BMI value: 23.8 kg/m2. The literature search revealed that probiotic/synbiotic administration improved enteric microbiota by increasing the abundance of beneficial bacteria such as Lactobacillus, Eubacterium, Peptostreptococcus, Bacillus and Bifidobacterium, and decreased the abundance of potentially harmful bacteria such as Fusobacterium, Porhyromonas, Pseudomonas and Enterococcus. Additionally, probiotic/synbiotic intervention improved release of antimicrobials, intestinal permeability, tight junction function in CRC patients.
Conclusions: The use of probiotics/synbiotics positively modulates enteric microbiota, improves postoperative outcomes, gut barrier function and reduces inflammatory parameters in patients suffering from CRC.
Keywords: chronic diseases; colorectal cancer; disease prevention; gut microbiota; human microbiome; micronutrients; probiotics; supplementation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity.Nutrients. 2020 Jan 15;12(1):222. doi: 10.3390/nu12010222. Nutrients. 2020. PMID: 31952249 Free PMC article. Clinical Trial.
-
Probiotics supplementation in patients with colorectal cancer: a systematic review of randomized controlled trials.Nutr Rev. 2021 Dec 8;80(1):22-49. doi: 10.1093/nutrit/nuab006. Nutr Rev. 2021. PMID: 34027974
-
The effects of probiotics on reducing the colorectal cancer surgery complications: A periodic review during 2007-2017.Clin Nutr. 2020 Aug;39(8):2358-2367. doi: 10.1016/j.clnu.2019.11.008. Epub 2019 Nov 9. Clin Nutr. 2020. PMID: 31831184
-
The effect of oral synbiotics on the gut microbiota and inflammatory biomarkers in healthy adults: a systematic review and meta-analysis.Nutr Rev. 2025 Feb 1;83(2):e4-e24. doi: 10.1093/nutrit/nuae002. Nutr Rev. 2025. PMID: 38341803 Free PMC article.
-
Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model.Appl Microbiol Biotechnol. 2020 Oct;104(20):8837-8857. doi: 10.1007/s00253-020-10863-x. Epub 2020 Sep 9. Appl Microbiol Biotechnol. 2020. PMID: 32902682
Cited by
-
Microbiome First Medicine in Health and Safety.Biomedicines. 2021 Aug 27;9(9):1099. doi: 10.3390/biomedicines9091099. Biomedicines. 2021. PMID: 34572284 Free PMC article. Review.
-
The role of microbiota in colorectal cancer.Folia Microbiol (Praha). 2022 Oct;67(5):683-691. doi: 10.1007/s12223-022-00978-1. Epub 2022 May 10. Folia Microbiol (Praha). 2022. PMID: 35534716 Review.
-
Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice.Front Cell Infect Microbiol. 2022 Jun 15;12:886061. doi: 10.3389/fcimb.2022.886061. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35782138 Free PMC article.
-
Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia.Gut. 2023 Jul;72(7):1240-1254. doi: 10.1136/gutjnl-2023-329429. Epub 2023 Apr 5. Gut. 2023. PMID: 37019620 Free PMC article.
-
Gut microbiomes and treatment-resistant ulcerative colitis: a case-control study using qPCR.BMC Microbiol. 2025 Apr 28;25(1):254. doi: 10.1186/s12866-025-03963-z. BMC Microbiol. 2025. PMID: 40295906 Free PMC article.
References
-
- Thun M., Linet M.S., Cerhan J.R., Haiman C.A., Schottenfeld D., editors. Cancer Epidemiology and Prevention. Volume 1. Oxford University Press; New York, NY, USA: 2017.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical